Prne
September 9th, 2009
NEW YORK -
Cohn & Wolfe, a leading global public relations agency, today announced that Linda Dyson has joined the firm as Executive Vice President and Global Healthcare Practice leader. She will report to Donna Imperato, CEO of Cohn & Wolfe.
Linda joins Cohn & Wolfe from Roche where, for the last three years, she was a public affairs and advocacy relations executive and company spokesperson. She directed strategy, marketing, and litigation communications across three business units, advised U.S. and global senior management, and served on cross-functional teams devoted to communications strategies, priorities and issues.
“Linda will bring great leadership and expertise to our clients and agency. She has a clear understanding of the challenges, needs and issues facing clients in today’s complex and rapidly changing healthcare environment,” said Donna Imperato. “Her appointment assures that Cohn & Wolfe will continue to provide one of the very best healthcare communications offerings - from product launches and issues and crisis management to full-scale digital and social media programs.”
Linda has two decades of global healthcare communications experience and brings tremendous expertise developing and executing the full spectrum of communications programs on behalf of pharmaceutical companies, healthcare systems, providers, government agencies and non-profit organizations. She has led more than 20 pharmaceutical/biotechnology product launches and supplemental indications globally, and is a seasoned issues and crisis management counselor.
“It’s a real thrill to join Cohn & Wolfe and lead a practice I have long admired for its smart, creative programs and informed, intelligent counsel,” said Linda. “I’m looking forward to working with a world-class roster of clients and an expert staff.”
Prior to joining Roche, Linda co-led the flagship New York healthcare practice for Ketchum, and held other senior leadership positions at healthcare communications firms, including Chandler Chicco, Edelman, and Vox Medica where she established pharmaceutical and biologics-based practices.
About Cohn & Wolfe and Cohn & Wolfe Healthcare
Cohn & Wolfe is a strategic public relations agency dedicated to creating, building and protecting the world’s most prolific brands. With offices around the world, the agency is committed to breaking new ground in the delivery of cross-channel media strategies, creative programming, and practice area excellence.
Cohn & Wolfe’s Healthcare Practice is one of the largest, full-service public relations consultancies in the world serving pharmaceutical, biotechnology, medical device and diagnostic companies as well as patient advocacy groups. With more than 300 healthcare professionals, the practice is renowned for its expertise across the entire healthcare communications spectrum.
Cohn & Wolfe is recognized year after year by clients and the industry for excellence in creativity, client service, digital communications, media strategy, senior management and strategic counsel. Cohn & Wolfe also consistently ranks among the top “Best Agencies to Work For” in an annual, industry-wide employee survey. For more information, visit: www.cohnwolfe.com. Cohn & Wolfe is part of WPP (Nasdaq: WPPGY), one of the world’s largest communications services group.
Source: Cohn & Wolfe
Eric Litchfield, +1-212-537-8145, Eric.Litchfield at cohnwolfe.com
Filed under Advertising, Business, Health, Health Care / Hospitals, Media, Personnel Announcements | Tags: Cohn & Wolfe, england, New York | Comment Below
Related Press Releases NASBA Rallies International RegulatorsSeptember 13th, 2009 NASHVILLE, Tennessee -
- 'IFRS, Liability Threats to Firms and Practice Inspections on the Table'
International regulators representing over 20 jurisdictions assembled in San Francisco on September 10-11, for the Second Annual Forum of International Accountancy Regulators. The Forum -- established by the National Association of State Boards of Accountancy (NASBA) in 2008 -- is a unique roundtable devoted to the exchange of issues and ideas related to the global impact of international accounting and auditing regulation. New Research Indicates 95% of Patients are in Moderate to Severe Chronic Pain Despite One Year of TreatmentSeptember 9th, 2009 EUROPEAN FEDERATION OF CHAPTERS OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (EFIC) CONGRESS, LISBON -
- Year-Long Tracking Survey Demonstrates That 19% Feel That Their Pain has Become Worse
95% of patients are suffering from moderate to severe chronic pain after one year of treatment[1] and only 12% are being prescribed strong opioids, according to a year-long survey presented today at the EFIC congress. The research reveals that more than half of patients' pain levels fail to improve over the course of a year's treatment and for 19%, their pain has become worse. The Mind Games Smokers Play When Trying to Quit Revealed in New SurveySeptember 7th, 2009 LONDON -
LONDON, September 8 /PRNewswire/ --
- New NiQuitin(R) Pre-Quit(TM) Lozenges Launched To Help Smokers Address Their Internal Struggle By Easing Into Quitting
New research results, which delve into the mind of smokers, are launched today, lifting the veil of nicotine addiction to understand the thoughts, anxieties and fears of the British smoker. The study, conducted on behalf of NiQuitin, shows that even smokers who are keen to kick the habit are torn between the benefits of giving up and the allure of cigarettes. Novel Chemotherapy Agent Bendamustine Significantly More Effective First-Line Therapy Than Chlorambucil in CLLAugust 3rd, 2009 CAMBRIDGE, England -
- Blood Marrow Normalised in 31% (Versus 2%) of Patients, With Manageable Side-Effects
Nearly a third (31%) of all bendamustine-treated patients saw all clinical evidence of their advanced chronic lymphocytic leukaemia (CLL) disappear when used as a first-line treatment option, according to the results of a large new multicentre phase III study published online by the Journal of Clinical Oncology today. Only 2% of patients treated with chlorambucil (the standard treatment) in the study achieved the same results.(1)
Professor Wolfgang U. Entrepreneurs Offered GBP100,000 Investment for Travel Industry's Next Big IdeaJune 23rd, 2009 LONDON -
- Nationwide Search Launched for a New Travel Business
The leading trade newspaper for the travel industry is offering a GBP100,000 prize to the individual or group with the most innovative idea for a new travel business. Travel Trade Gazette (TTG) is offering the incredible recession-busting prize in a Dragon's Den-style competition called The Big Idea, sponsored by Dubai Tourism. New NICE Guideline for Type 2 Diabetes Recognises Benefits From Newer Agents for Blood Glucose ControlMay 26th, 2009 LONDON - For Healthcare and Pharmaceutical Correspondents Only
- NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients
Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the UK, which recommends considering a range of newer therapy options, including 'Januvia' (sitagliptin). The guideline recommends that the DPP-4 inhibitor class, which includes sitagliptin, should be considered as a second line therapy instead of a sulphonylurea (SU) when blood glucose control remains or becomes inadequate (HbA1c greater than or equal to 6.5% or other higher level agreed with the individual) with metformin in patients at significant risk of hypoglycaemia or its consequences, or if a patient does not tolerate an SU or an SU is contraindicated.(1)
Professor Anthony Barnett, a leading diabetologist from the UK said, "One of the key issues when considering treatment options is striking a balance between achieving optimal glycaemic control while also minimising the risk of hypoglycaemia, and the newer treatments provide us with a wider choice of options. Marks & Spencer - Results Interview With ChairmanMay 18th, 2009 LONDON - In a video interview M&S Chairman Stuart Rose looks at the UK retailer's results for the 52 weeks ended 28 March 2009. He discusses current trading, performances in the group's Food and General Merchandise businesses, International and Online operations, the 20:20 change programme plus outlook. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical LiaisonApril 28th, 2009 COMMACK, New York - It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Loma Linda University ResearchApril 12th, 2009 LOMA LINDA, California - Loma Linda University research just published in the American Journal of Clinical Nutrition compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease. RAPS Offers New International Regulatory Affairs Certification - RAC (GS)April 6th, 2009 ROCKVILLE, Maryland - New RAC Credential Focuses on General Scope of Regulatory Practice, International Standards
The Regulatory Affairs Professionals Society (RAPS) has announced its newest Regulatory Affairs Certification (RAC), the RAC General Scope (GS). The RAC (GS) credential denotes knowledge related to the general scope of practice of regulatory professionals in the healthcare product sector, regardless of geographic location or in which regions they may be involved.
Related News Louisville QB Tyler Wolfe to transfer, making battle for starting job 2-man competitionApril 23rd, 2009 Louisville QB Wolfe to transferLOUISVILLE, Ky. — Louisville quarterback Tyler Wolfe is leaving the team. Healthcare Realty Trust replaces Wabash National in S&P SmallCap 600July 10th, 2009 Healthcare Realty Trust joins S&P SmallCap 600NEW YORK — Healthcare Realty Trust Inc. will replace truck-trailer manufacturer Wabash National Corp. Show-biz talent agent Sam Cohn, who repped a pantheon of stars, dies at 79May 8th, 2009 Show-biz talent agent Sam Cohn dies at 79NEW YORK — Sam Cohn, a powerful talent agent for some of Hollywood and Broadway's biggest stars as well as a pantheon of directors, writers and playwrights, has died. He was 79. Family friend David Richenthal said Cohn died Wednesday at New York Presbyterian Hospital after a brief illness. Analyst lifts FedEx 2 notches to 'Outperform,' citing better volume, shaky competitorAugust 28th, 2009 Analyst lifts FedEx 2 notches to 'Outperform'NEW YORK — An analyst upgraded shares of FedEx Corp. to "Outperform" from "Underperform," saying slight improvements in global package volume, wage cuts and the possible bankruptcy of a major trucking company will drive earnings — and in turn, shares — higher. Healthcare Realty Trust declared dividend of 38.5 cents, payable Sept. 4August 11th, 2009 Healthcare Realty declares dividend of 38.5 centsNASHVILLE, Tenn. —Healthcare Realty Trust Inc. Now, a bicycle that takes around 20 seconds to fold downAugust 4th, 2009 LONDON - A British student has designed a bicycle that can be folded completely into the space of the wheel's 26-inch circumference within 20 seconds. According to a report by Sky News, Dominic Hargreaves' bicycle, named 'The Contortionist', takes around 20 seconds to fold down, and has been shortlisted for this year's James Dyson Award for innovation. Deloitte's Charu Sehgal recognized as one of the top 20 women achievers in healthcareApril 23rd, 2009 NEW DELHI - Modern Medicare, a leading magazine on healthcare business news, has felicitated Charu Sehgal, Senior Director, Strategy and Operations Division and Head, Healthcare Vertical, Deloitte India, as one of the top 20 women achievers of the Indian healthcare industry. This recognition is bestowed on women professionals who have made a significant, positive contribution to the development of the healthcare sector in India. Apollo Hospitals in Companion Global Healthcare networkDecember 23rd, 2008 WASHINGTON - The Apollo Hospitals in Bangalore and Delhi have been accepted into a US medical travel company's network of international hospitals for getting medical care outside the US at affordable prices. With the acceptance of the two Indian facilities by Companion Global Healthcare Inc, it can arrange travel, set appointments and provide other services to its individual clients and US employer group members who choose treatment at either facility. Deloitte names Avinash Gupta as national leader for its financial advisory practiceApril 8th, 2009 NEW DELHI - Deloitte today announced the appointment of Avinash Gupta as the national leader for its financial advisory practice. Deloitte's Financial Advisory practice comprises Corporate Finance, Forensic and Dispute Services, Transaction Services, Reorganization Services and Valuation Services. Cup points leader, pole-sitter Stewart wrecks car in Pocono practice, goes to backupJune 6th, 2009 Cup leader Stewart wrecks car in Pocono practiceLONG POND, Pa. — NASCAR points leader Tony Stewart has wrecked his car during practice at Pocono Raceway and had to go to a backup car.
|
|
